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Background: Out-of-hospital cardiac arrest (OHCA) is a leading cause of death and severe
neurological disability. The objective of this study was to identify clinical predictors of early
neurological outcome in survivors of OHCA managed according to recent recommenda-
tions for OHCA care.
Methods: Data from survivors of OHCA, admitted to a tertiary cardiac intensive care unit
and treated with hypothermia in a 22 months period (n ¼ 46, age 60713 years, 74% males)
were retrospectively evaluated. At 1-month follow-up, patients were classified according to
the best achieved Glasgow–Pittsburgh cerebral performance categories (CPC 1–5) and
factors affecting the outcome were analysed.
Results: At 1-month follow-up, 23 patients (50%) had favourable outcome (CPC 1–2), while
23 patients (50%) had poor outcome (CPC 3–5), including 19 with in-hospital death (41% of
total). Patients with good outcome were younger (55713 years vs. 66710 years; P ¼ 0.003),
had more often myocardial infarction as the cause of arrest (63% vs. 30%; P ¼ 0.018) and
ventricular fibrillation/tachycardia as an initial rhythm (78% vs. 39%; P ¼ 0.007). Both
groups differed by lactate level on admission (4.074.6 vs. 7.374.1 mmol/l, P ¼ 0.02), after
12 h (2.571.1 vs. 4.373.2 mmol/l, P ¼ 0.04) and after 24 h (1.971.2 vs. 3.271.9 mmol/l,
P ¼ 0.04). Logistic regression revealed the following independent outcome predictors: age,
acute myocardial infarction and admission lactate level.
Conclusion: Favourable outcomewas observed in a half of OHCA survivors. Young age, acute
myocardial infarction as underlying aetiology of cardiac arrest, and low lactate level on
admission were the best predictors of favourable outcome.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z.o.o. All
rights reserved.1. Introduction
Sudden cardiac arrest is the leading cause of death in
industrialized countries [1,2]. Although recent data suggest
decreasing incidence of out-of-hospital cardiac arrest (OHCA),
prognosis remains very dubious. Survival rates are variable
and depend not only on pre-hospital but also on post-
resuscitation in-hospital care [3,4]. Previous studies demon-
strated significant institutional and regional differences inch Society of Cardiology.
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, baal@medicon.cz (B. Aldsurvival after OHCA [5,6]. Over the past-half century, many
interventions improved the rate of restoration of spontaneous
circulation (ROSC) but without impacting long-term survival
[3]. During this period, major indicators for increased survival
rate have not changed: younger age, VF/VT as initial rhythm,
witnessed cardiac arrest, bystander cardiopulmonary resus-
citation (CPR), and time elapsed to ROSC [7–9]. During the past
few years, new pre-hospital and in-hospital therapeutic
approaches have been introduced to improve outcome. ThesePublished by Elsevier Urban & Partner Sp.z.o.o. All rights reserved.
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gency line dispatcher, early induction of mild therapeutic
hypothermia, urgent percutaneous coronary intervention in
victims of OHCA due to acute myocardial infarction with ST
elevations, and implantation of cardioverter-defibrillators
before hospital discharge [10–12]. However, the prediction of
the neurologic outcome with use of these novel procedures is
not well defined. As hypothermia and accompanying sedation
affects traditional indicators of preserved brain function, like
level of consciousness or brainstem reflexes, it is important to
identify early predictors of neurological outcome even during
hypothermia treatment. The objective of this study was to
evaluate the predictors of outcome in adult OHCA survivors
admitted to a tertiary cardiac intensive care unit (ICU) with
implemented recent recommendations for OHCA care.2. Methods
2.1. Patients
In this retrospective cohort study, we analysed consecutive
comatose adult patientswith OHCA and ROSC (using the Utstein
style definition) whowere treated with therapeutic hypothermia
[13]. These patients were admitted to cardiac ICU at Institute for
Clinical and Experimental Medicine (IKEM) between January
2007 and October 2008. In all patients, standard medical
management including invasive arterial pressure monitoring,
close blood glucose control (insulin infusion to reach goal
plasma glucose level of 6–10mmol/l), and controlled mechanical
ventilation with maintenance were provided in accordance with
standard recommendations [3]. In order to maintain mean
arterial pressure Z65mmHg and adequate tissue perfusion,
hemodynamic support with noradrenaline (norepinephrine)
and/or dobutamine was necessary in some patients. Immediate
therapeutic hypothermia at admission using a cooling device
(Blanketrols II Hyper-Hypothermia System) alone or combined
with initial ice-cold saline infusion (10ml/kg) and ice packs on
the patient’s axilla and groin were deployed. The target core
body temperature was 33 1C, measured by temperature-sensing
thermistor urinary bladder catheter and maintained for 12–24 h.
Re-warming was active and performed with a Blanketrol device.
Rebound hyperpyrexia has been defined as at least two
temperature readings above 37.5 1C during first 5 h after cooling
cessation and achievement of normothermia. Patients with
signs of acute infection (2 patients, 5%) or thosewho died during
hypothermia (3 patients, 7%) were excluded and the remaining
41 patients were included in the sub-analysis of rebound
hyperpyrexia. Sedation drug propofol and muscular relaxant
pancuronium or pipecuronium were titrated to suppress shiver-
ing. All patients underwent an echocardiography evaluation.
Urgent coronary artery catheterization in patients presenting
with acute STEMI and direct percutaneous coronary interven-
tion, if indicated were performed.
2.2. Organization of regional emergency medical system
(EMS) care for OHCA
The city of Prague has a population of 1,226,697 inhabitants
and covers an area of 496 km2. Out-of-hospital care in Pragueis provided by two types of mobile ambulances: rapid
response units with a physician and advanced life support
(ALS) units (ambulance vehicles comprising of a paramedic
and a driver/rescue person). Emergency calls from the entire
area of Prague are accepted continuously at a toll-free number
and managed by a Medical Operation Centre handling over
255,000 emergency calls per year. All operators are qualified to
guide cardiopulmonary resuscitation. Emergency crews han-
dle approximately 500 adult OHCAs per year. Patient’s clinical
data, including suspected time of arrest, whether the arrest
was witnessed, any pre-arrival resuscitation attempts and
therapy provided by emergency medical service, and compli-
cations during transport to hospital are recorded by EMS
personnel and were used as a source document. IKEM is a
governmental tertiary health care facility specialized in
advanced cardiovascular care and organ transplantation.
The Heart Centre at IKEM provides round o’clock direct PCI
service for acute STEMI with a volume of 300 direct PCI’s per
year. The Cardiac ICU at IKEM has 18 beds, taking care of an
average of 1300 patients per year. Data were collected from
EMS patient sheets, in-hospital patient records and final
medical records if the patient was transferred. Time of onset
of cardiac arrest was estimated from information provided by
eye-witnesses.2.3. Study endpoint
The primary endpoint was survival with favourable neurolo-
gical outcome at 1-month follow-up. Neurological state was
classified according to the best-achieved Glasgow–Pittsburgh
cerebral performance categories (CPC 1: no or mild neurolo-
gical disability; CPC 2: moderate neurological disability; CPC 3:
severe neurological disability; CPC 4: coma, vegetative state;
CPC 5: death, brain death). The favourable outcome was
defined as CPC 1 or CPC 2.2.4. Statistical analysis
Statistics were performed with SPSS statistical software (SPSS
Inc, Chicago, IL, USA, 17.0). Continuous data are shown as
mean7standard deviation, or as median with inter-quartile
range (IQR) and compared by use of a two-tailed t-test, or
if not normally distributed with the Mann–Whitney test.
Categorical data are presented as absolute or relative
frequencies and are analysed by the Pearson w2 test or Fisher’s
exact test in the presence of small numbers. A P value o0.05
was considered significant. Lactate clearance was calculated
as the difference from baseline to 24 h after admission
divided by the baseline value and multiplied by 100. To
identify a parsimonious set of variables predicting favourable
(CPC 1–2) or bad outcome (CPC 3–5), a multivariate logistic
regression analysis with backward elimination based on
likelihood if ratios (probability for removal P40.10) was used.
Characteristics significantly associated with poor outcome
and/or from a clinical point of view may have influence
outcome were included (listed bellow and marked by
asterisks in Tables 1 and 2). Goodness-of-fit was tested with
Hosmer–Lemeshow test.
Table 1 – Basic characteristics of the cohort.
All patients
(N ¼ 46)
Outcome P-value
Good
(CPC 1–2)
(N ¼ 23)
Poor
(CPC 3–5),
(N ¼ 23)
Male gender 34 (74%) 20 (87%) 14 (61%) 0.09
Mean age (years) 60.2712.7 54.8712.4 65.6710.3 0.003
History
Hypertension 24 (54%) 12 (52%) 15 (65%) 0.2
Diabetes 12 (26%) 4 (17%) 8 (35%) 0.3
Coronary artery disease 9 (20%) 2 (10%) 10 (44%) 0.1
Smoking 15 (33%) 9 (39%) 6 (26%) 0.5
Medication
Beta blocker 13 (28%) 3 (13%) 12 (52%) 0.02
Ca-channel blocker 5 (11%) 3 (13%) 3 (13%) 0.7
ACE inhibitor or ARB (39%) 7 (30%) 11 (48%) 0.2
Statin 9 (20%) 2 (9%) 6 (26%) 0.3
Left ventricular ejection fraction (%) 31713 31714 31713 0.9
Underlying aetiology
Coronary artery disease 31 (67%) 17 (74%) 14 (61%) 0.3
Dilated cardiomyopathy 5 (11%) 3 (13%) 2 (9%) –
Other 10 (22%) 3 (17%) 7 (30%) –
Respiratory failure for COPD 2 (4%) 1 (4%) 2 (9%) –
Idiopathic VF 4 (8%) 1 (4%) 2 (9%) –
Undetermined 4 (8%) 1 (4%) 3 (13%) –
Acute myocardial infarction 22 (48%) 15 (65%) 7 (30%) 0.02
STEMI 16 (35%) 11 (48%) 5 (22%) 0.16
VF/VT 27 (59%) 18 (78%) 9 (39%) 0.007
Witnessed cardiac arrest 39 (85%) 20 (87%) 19 (83%) 0.7
Bystander basic life support 29 (63%) 17 (74%) 12 (52%) 0.2
Time from cardiac arrest to ALS initiation, min (median, IQR) 8 (5–10) 8 (5–10) 8 (6–12) 0.3
Time from ALS initiation to ROSC, min. (median, IQR) 10 (6–22) 6 (3–14) 11 (6–28) 0.06
Time from cardiac arrest to ROSC, min. (median, IQR) 19 (11–29) 18 (10–26) 22 (15–45) 0.1
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; COPD, chronic obstructive pulmonary disease;
VF, ventricular fibrillation; STEMI, ST segment elevation myocardial infarction; VT, ventricular tachycardia; ALS, advanced life support;
IQR, interquartel range; ROSC, return of spontaneous circulation.
n Characteristics included in multivariate regression analysis.
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3.1. Basic characteristics of study population
During a period of 22 months, 881 patients were presented
with OHCA in the city of Prague. ROSC was successfully
achieved in 336 (38%) patients and 59 (6%) patients were
admitted to the ICU at IKEM in whom physician of EMS crew
assumed cardiac aetiology. Hypothermia was indicated and
performed in 46 comatose patients (34 men, 12 women; mean
age 60.2712.7 years; range: 19–83 years) who constituted the
cohort of our study. Of those in whom hypothermia was not
indicated 12 patients were conscious and one patient had
melaena on admission. Demographic and clinical character-
istics of the cohort are shown in Table 1. The first monitored
rhythm on the scene was ventricular fibrillation or pulseless
ventricular tachycardia (VF/VT) in 27 (59%) patients, and
asystole in 14 (30%) or pulseless electrical activity in 5 (11%)
patients. The underlying aetiology of cardiac arrest was
coronary artery disease (n ¼ 31, 67%), dilated cardiomyopathy(n ¼ 5, 11%), or other aetiology (n ¼ 10, 22%) as specified in
Table 1. Among patients with coronary artery disease (n ¼ 31),
22 (71%) patients presented with acute myocardial infarction
(16 patients with STEMI) and 17 of them underwent direct PCI.
The first documented rhythm at the scene was VF/VT in 61%
patients of coronary artery disease group, 80% of dilated
cardiomyopathy group, and in 40% patients of other aetiology.
Basic life support was provided by a bystander in 63% cases.
Average time from cardiac arrest to the initiation of ALS was
8.474.3 min (median 8, IQR: 5–10). Average time from ALS to
ROSC was 16716 min (median 10, IQR: 6–22) and average time
from cardiac arrest to ROSC was 24717 min (median 19,
IQR: 11–29).3.2. Provided therapy
Therapeutic hypothermia was provided in all 46 patients. The
time from admission to achievement of a goal temperature of
33 1C was 5.072.2 h (median 4.0, IQR: 3–6). Urgent PCI was
performed in all patients who presented with STEMI (16 pts,
Table 2 – Therapeutic processes and physiological variables at admission and during the initial 24 h.
Characteristics All patients
(N ¼ 46)
Outcome P-value
Good
(CPC 1, 2)
(N ¼ 23)
Poor
(CPC 3–5)
(N ¼ 23)
Time from admission to achieving goal temperature (h) 5.072.2 5.372.5 4.671.8 0.5
Urgent percutaneous coronary intervention 17 (37%) 12 (52%) 5 (22%) 0.05
Intra-aortic balloon pump 2 (4%) 2 (9%) 0
Inotropic agents 24 (52%) 15 (65%) 17 (74%) 1.00
Rebound hyperpyrexia analysed in 41 patients 22 (54%) 12 (55%) 10 (45%) 0.8
Glycaemia (mmol/l)
Admission 14.575.7 13.875.2 15.376.3 0.4
After 12 h 10.975.1 9.973.7 11.976.1 0.2
After 24 h 10.775.1 9.173.9 12.375.7 0.04
pCO2 (kPa)
Admission 6.572.3 6.472.3 6.672.4 0.8
After 12 h 5.171.1 4.970.7 5.271.5 0.4
After 24 h 4.870.7 4.670.6 4.970.8 0.2
BE (mmol/l)
Admission 5.276.3 3.376.7 7.175.4 0.04
After 12 h 3.574.6 2.673.3 4.575.5 0.2
After 24 h 4.7711.3 2.473.3 7.2715.5 0.158
Lactate (mmol/l)
Admission 5.874.1 4.074.6 7.374.1 0.024
After 12 h 3.472.6 2.571.1 4.373.2 0.045
After 24 h 2.671.7 1.971.2 3.271.9 0.040
Lactate clearance (%), median (IQR) 58 (46–79) 50 (32–79) 58 (51–75) 0.6
MAP (mmHg)
Admission 91723 92720 89726 0.600
After 12 h 85716 86718 84714 0.641
After 24 h 80723 79713 80730 0.888
Abbreviations: pCO2, partial pressure of carbon dioxide; BE, base excess; MAP, mean arterial pressure.
n Characteristics included in multivariate regression analysis.
Fig. 1 – Patients admitted to the ICU after OHCA and
outcomes of 46 patients who were indicated and treated
with hypothermia.
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two patients (4%), intra-aortic balloon pump was used for
hemodynamic support after PCI. The median duration of the
intensive care was 6 day (IQR: 4–10). Implantable cardioverter-
defebrillator implantation had been performed in 8 (35%)
patients who were then discharged home. Rebound hyperpyr-
exia according to definition above occurred in 22 (54%) cooled
patients having almost the same prevalence in good and poor
outcome groups (50% vs. 45%; P ¼ 0.7). Mean blood glucose
level was 14.575.7, 10.975.1, and 10.775.1 mmol/l on admis-
sion, after 12 h, and 24 h after admission, respectively.
3.3. Outcome variables
At 1-month follow-up, 23 patients (50%) had favourable outcome
(CPC 1–2), while 23 patients (50%) had poor outcome (CPC 3–5),
including 19 with in-hospital death (CPC 5, 41% of total) (Figs. 1
and 2). Both groups differed in age (54.8712.7 years vs. 65.6710.3
years; P ¼ 0.003), occurrence of VF/VT as an initial rhythm (78%
vs. 39%; P ¼ 0.007), incidence of acute myocardial infarction as
the underlying aetiology of cardiac arrest (63% vs. 30%; P ¼ 0.02),
and a history of beta-blocker therapy (13% vs. 52%; P ¼ 0.02).
Regarding laboratory parameters, the good outcome group had
significantly lower lactate level at admission, 12 h and 24 h aftercardiac arrest (4.474.6 vs. 7.374.1 mmol/l; P ¼ 0.02, 2.571.1 vs.
4.373.2 mmol/l; P ¼ 0.04, 1.971.2 vs. 3.271.9 mmol/l; P ¼ 0.04,
respectively) (Table 2). Lactate clearance was similar in both
groups (median 50%, IQR: 32–79 vs. 58, IQR: 51–75, P ¼ 0.6).
Fig. 2 – The outcome of patients after 1-month follow-up
presented in CPC categories.
Fig. 3 – Correlation between the lactate level on admission
and the time from cardiac arrest to ROSC (r ¼ 0.512;
P ¼ 0.002).
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tion of the initial lactate level with the outcome (OR 1.412, 95% CI
1.054–1.892; P ¼ 0.02). Furthermore, we found a correlation
between lactate level at admission and the time from cardiac
arrest to ROSC (r ¼ 0.512; P ¼ 0.002) (Fig. 3).3.4. Independent predictors of favourable outcome
The following variables were included in multivariate logistic
regression model: age, VF/VT as the first documented rhythm
on the scene, myocardial infarction as the underlying
aetiology of cardiac arrest, lactate level on admission, and
the time from cardiac arrest to ROSC. The Homser–Lemeshow
test indicated that the model adequately fits the data
(w2 ¼ 10.8, df ¼ 8, P ¼ 0.2). Favourable outcome (CPC category
1–2 at 30 day after admission) was associated with younger
age, myocardial infarction as the underlying aetiology of
cardiac arrest and lower level of lactate on admission
(Table 3).4. Discussion
Despite decades of therapeutic changes for OHCA, the
survival with favourable neurological outcome remains very
poor. The main objectives of this study were to present our
experience with the latest therapeutic approaches influen-
cing beneficially survival rate after OHCA, and to identify
predictors of survival with favourable outcome after imple-
mentation of these approaches.
Prevalence of survival with favourable neurological out-
come (CPC 1–2) at 1-month of follow-up in our 46 analysed
patients reached 50%. This high proportion of successful
outcome is similar to the original work of Bernard and
colleagues in 43 patients who were also treated with
hypothermia [11]. However, it is higher in comparison to
previous studies from other centres, which may be due to
several reasons [6,14–19]. Firstly, as reported in previous
studies, majority of circulatory arrests are of cardiac aetiology
[20,21]. In the present study, cardiac aetiology of the arrest
was confirmed in 67% of patients. In addition, high proportion
of cases suffered from acute myocardial infarction as under-
lying aetiology of the arrest (overall 48% and STEMI in 35%
patients). This may reflect a specific situation in the Czech
Republic as all patients with suspected acute myocardial
infarction are transported primarily to specialized centres
with catheterization laboratories. Secondly, cardiac arrest due
to VF or VT is generally associated with better survival rate
after OHCA [22–24]. VF or VT are amenable to early defibrilla-
tion and indicate collapse of the circulation without previous
global hypoxia. This is in agreement with our findings, where
VF/VT was present in 59% of patients and the survival rate
after ICU admission in this subgroup reached 67% (ROSC
median 6 min, IQR: 4–14). On the other hand, the survival rate
of patients with documented asystole or pulseless electrical
activity was only 26% (ROSC median 11 min, IQR: 6–28).
Finally, our results may reflect the efficacy of EMS in the city
of Prague.
However, other factors may affect the outcome after OHCA.
In the present study, we did not analyse the prevalence of
cardiogenic shock after ROSC because it could not have been
accurately defined. On the other hand, both ionotropic agents
and intra-aortic balloon pump were used in our population
with similar frequency. This is in agreement with previous
studies, where cardiogenic shock did not affect the effective-
ness of post-OHCA therapy [12,25].
Interestingly, an association between beta blocker therapy
and poor outcome was found. This association may be due to
the fact that the majority of subjects in the present study who
had been on beta blocker therapy had also had CAD history.
These patients with CAD history probably had more severe
health status before cardiac arrest, which could adversely
affect their outcome after cardiac arrest.
Hyperpyrexia has been associated with significantly in-
creased risk of brain death after OHCA [6,26,27]. The interna-
tional Liaison Committee on Resuscitation (ILCOR)
recommended the use of hypothermia after VF and OHCA
as it improves the neurological outcome of comatose patients
after cardiac arrest [3,11,12,28]. Hyperpyrexia is commonly
observed after re-warming from hypothermia. However, it
Table 3 – Predictors of favourable neurological outcome, final multivariate model.
Prognostic factor Adjusted odds ratio 95% CI P-value
Age (years) 1.142 1.023–1.274 0.02
Acute myocardial infarction as underlying aetiology of cardiac arrest 0.052 0.005–0.552 0.01
Lactate on admission (mmol/l) 1.436 1.063–1.941 0.02
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cooling is associated with adverse outcome. In this study,
rebound hyperpyrexia occurred with similar frequency in
good and poor outcome groups.
Some studies reported that hyper- or hypoglycaemia can be
associated with brain injury after OHCA [29,30]. Hyperglycae-
mia is common in patients after successful cardiac resuscita-
tion from OCHCA and is associated with poor neurological
outcome [29,30]. However, strict control of blood glucose
levels may lead to harmful hypoglycaemia [31]. The multi-
center analysis of patients admitted to ICU after cardiac arrest
demonstrated an association between hospital mortality and
the lowest blood glucose concentration measured during the
first 24 h [13]. Beiser et al. [32] have recently published a paper
confirming a U-shaped relationship between maximum and
minimum blood glucose and hospital survival in non-diabetic
patients after cardiac arrest. This suggests that in patients
resuscitated after cardiac arrest, a mild hyperglycaemia
should be targeted. However, there is no consensus on blood
glucose measures best correlate with outcome. In the present
study, the target value of blood glucosewas below 10.0 mmol/l
and analysed three values; at admission, after 12 h and after
24 h of admission. In the good outcome group, the blood
glucose level was well controlled with a mean glycaemia
below 10 mmol/l. Blood glucose level measured 24 h after
admission might be a good indicator of worse outcome while
patients with poor outcome had significantly higher glucose
level (9.173.9 mmol/l vs. 12.375.7 mmol/l; P ¼ 0.04).
Other studies have evaluated the significance of lactate
level in patients with ROSC after cardiac arrest [19,33]. Lactate
is a byproduct of anaerobic metabolism after glycolysis and
is often considered as a measure of tissue hypoxia. Not
surprisingly, some authors have documented an association
between plasma lactate level on admission and neurological
outcome after OHCA for VF [34]. Similar findings have been
found in a recently published prospective study in patients
treated with hypothermia after cardiac arrest [19]. In the
present study, there were statistical differences between
patients with good and poor outcome not only in the baseline
lactate level, but also in samples obtained 12 h and 24 h later.
Although we found a correlation between the plasma lactate
level on admission and the time from cardiac arrest to ROSC,
lactate level on admission was a stronger predictor of
outcome rather than the mean time of ROSC. This suggests
that the quality of early CPR (level of global hypoxia), rather
than time to ROSC is more relevant for outcome after OHCA.
This is in agreement with a previous report from Oddo and
colleagues, where lactate level on admission was important
outcome predictor independently of time of ROSC [19]. Higher
lactate level in the poor outcome group after 24 h of
admission could be explained either as a hypoxia-relatedhigher production in the tissue or as a result of reduction in
lactate clearance. Since the calculated 24 h lactate clearance
was similar in both study groups, we believe that the higher
lactate level persisting 24 h after OHCA in the poor outcome
group was due to persisting tissue hypoxia. Along these lines,
Rivers et al. [35] have shown a significant impairment of
systemic oxygen extraction in post cardiac arrest patients.
Reasons for such a defect in systemic oxygen utilization may
reflect a persistence of microcirculatory dysfunction or an
intracellular enzymatic defect.
Our study had several limitations. Firstly, it is a retro-
spective, non-randomized, single centre observational study.
Secondly, our cohort may not represent all patients with
OHCA. Due to the existence of direct PCI capacity in our
centre, patients with OHCA due to VF in STEMI may be more
represented.5. Conclusions
After implementation of recent advances in post-arrest
resuscitation care into clinical practice, a favourable outcome
was reached in half of OHCA survivors treated at our hospital.
Lower age, acute myocardial infarction as a cause of the arrest
and lower initial lactate level were found useful predictors of
favourable outcome in patients treated according to the
recent treatment recommendations of OHCA.Conflicts of interest
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